Literature DB >> 25638345

Congenital Heart Disease: Causes, Diagnosis, Symptoms, and Treatments.

RongRong Sun1, Min Liu1, Lei Lu1, Yi Zheng1, Peiying Zhang2.   

Abstract

The congenital heart disease includes abnormalities in heart structure that occur before birth. Such defects occur in the fetus while it is developing in the uterus during pregnancy. About 500,000 adults have congenital heart disease in USA (WebMD, Congenital heart defects medications, www.WebMD.com/heart-disease/tc/congenital-heart-defects-medications , 2014). 1 in every 100 children has defects in their heart due to genetic or chromosomal abnormalities, such as Down syndrome. The excessive alcohol consumption during pregnancy and use of medications, maternal viral infection, such as Rubella virus, measles (German), in the first trimester of pregnancy, all these are risk factors for congenital heart disease in children, and the risk increases if parent or sibling has a congenital heart defect. These are heart valves defects, atrial and ventricular septa defects, stenosis, the heart muscle abnormalities, and a hole inside wall of the heart which causes defect in blood circulation, heart failure, and eventual death. There are no particular symptoms of congenital heart disease, but shortness of breath and limited ability to do exercise, fatigue, abnormal sound of heart as heart murmur, which is diagnosed by a physician while listening to the heart beats. The echocardiogram or transesophageal echocardiogram, electrocardiogram, chest X-ray, cardiac catheterization, and MRI methods are used to detect congenital heart disease. Several medications are given depending on the severity of this disease, and catheter method and surgery are required for serious cases to repair heart valves or heart transplantation as in endocarditis. For genetic study, first DNA is extracted from blood followed by DNA sequence analysis and any defect in nucleotide sequence of DNA is determined. For congenital heart disease, genes in chromosome 1 show some defects in nucleotide sequence. In this review the causes, diagnosis, symptoms, and treatments of congenital heart disease are described.

Entities:  

Keywords:  Chromosomal abnormalities; Congenital heart disease; Viral infection

Mesh:

Year:  2015        PMID: 25638345     DOI: 10.1007/s12013-015-0551-6

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  44 in total

1.  Harnessing fetal and adult genetic reprograming for therapy of heart disease.

Authors:  Shyam Sundar Nandi; Paras Kumar Mishra
Journal:  J Nat Sci       Date:  2015-04

Review 2.  Elevated serum levels of ghrelin and TNF-α in patients with cyanotic and acyanotic congenital heart disease.

Authors:  Sai Zhang; Gong-Liang Guo; Li-Li Yang; Li-Qun Sun
Journal:  World J Pediatr       Date:  2016-11-15       Impact factor: 2.764

3.  Associations of depression severity with heart rate and heart rate variability in young adults across normative and clinical populations.

Authors:  Laura M Lesnewich; Fiona N Conway; Jennifer F Buckman; Christopher J Brush; Peter J Ehmann; David Eddie; Ryan L Olson; Brandon L Alderman; Marsha E Bates
Journal:  Int J Psychophysiol       Date:  2019-06-10       Impact factor: 2.997

4.  Risk of Dementia in Adults With Congenital Heart Disease: Population-Based Cohort Study.

Authors:  Carina N Bagge; Victor W Henderson; Henning B Laursen; Kasper Adelborg; Morten Olsen; Nicolas L Madsen
Journal:  Circulation       Date:  2018-02-12       Impact factor: 29.690

5.  Mitomycin-Treated Endothelial and Smooth Muscle Cells Suitable for Safe Tissue Engineering Approaches.

Authors:  Irina Zakharova; Shoraan Saaya; Alexander Shevchenko; Alena Stupnikova; Maria Zhiven'; Pavel Laktionov; Alena Stepanova; Alexander Romashchenko; Lyudmila Yanshole; Alexander Chernonosov; Alexander Volkov; Elena Kizilova; Evgenii Zavjalov; Alexander Chernyavsky; Alexander Romanov; Andrey Karpenko; Suren Zakian
Journal:  Front Bioeng Biotechnol       Date:  2022-03-11

Review 6.  Role of Posttranslational Modifications of Proteins in Cardiovascular Disease.

Authors:  Yong-Ping Liu; Tie-Ning Zhang; Ri Wen; Chun-Feng Liu; Ni Yang
Journal:  Oxid Med Cell Longev       Date:  2022-07-09       Impact factor: 7.310

7.  Prevalence of Congenital Heart Disease in Chinese Children With Different Birth Weights and Its Relationship to the Neonatal Birth Weight.

Authors:  Hui Yan; Bo Zhai; Ruiling Feng; Penggao Wang; Yaodong Zhang; Yiran Wang; Yuwei Hou; Yang Zhou
Journal:  Front Pediatr       Date:  2022-05-19       Impact factor: 3.569

8.  Congenital Heart Defects and Dysmorphic Facial Features in Patients Suspicious of 22q11.2 Deletion Syndrome in Southern Brazil.

Authors:  Bruna Lixinski Diniz; Andressa Schneiders Santos; Andressa Barreto Glaeser; Bruna Baierle Guaraná; Cláudia Fernandes Lorea; Juliana Alves Josahkian; Janaína Huber; Rafael Fabiano Machado Rosa; Paulo Ricardo Gazzola Zen
Journal:  J Pediatr Genet       Date:  2020-06-17

Review 9.  N6-Adenosine Methylation (m6A) RNA Modification: an Emerging Role in Cardiovascular Diseases.

Authors:  Ye-Shi Chen; Xin-Ping Ouyang; Xiao-Hua Yu; Petr Novák; Le Zhou; Ping-Ping He; Kai Yin
Journal:  J Cardiovasc Transl Res       Date:  2021-02-25       Impact factor: 4.132

10.  Is heart disease a risk factor for low dementia test battery scores in older persons with Down syndrome? Exploratory, pilot study, and commentary.

Authors:  Maire E Percy; Walter J Lukiw
Journal:  Int J Dev Disabil       Date:  2017-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.